gefitinib and erlotinib are two drugs that effectively inhibit cell proliferation driven by oncogenic her alleles, but unlike cetuximab or herceptin, they paradoxically increase the levels of these receptors on the plasma membrane. what is the mechanism of action for gefitinib and erlotinib?